1. Home
  2. IMRX vs DERM Comparison

IMRX vs DERM Comparison

Compare IMRX & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$3.62

Market Cap

232.3M

Sector

Health Care

ML Signal

HOLD

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$4.97

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMRX
DERM
Founded
2008
2014
Country
United States
United States
Employees
57
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
232.3M
190.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
IMRX
DERM
Price
$3.62
$4.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
★ $17.17
$13.75
AVG Volume (30 Days)
★ 663.1K
188.6K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.75
34.72
EPS
N/A
★ N/A
Revenue
N/A
★ $61,858,000.00
Revenue This Year
N/A
$29.45
Revenue Next Year
N/A
$62.50
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 10.20
52 Week Low
$3.38
$4.31
52 Week High
$8.48
$9.56

Technical Indicators

Market Signals
Indicator
IMRX
DERM
Relative Strength Index (RSI) 35.41 27.89
Support Level N/A $4.84
Resistance Level $5.32 $5.50
Average True Range (ATR) 0.18 0.35
MACD -0.02 -0.14
Stochastic Oscillator 31.18 9.95

Price Performance

Historical Comparison
IMRX
DERM

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Share on Social Networks: